… Monotherapy with rifaximin (Xifaxin; Salix Pharmaceuticals) proved … randomized controlled clinical trials, were presented … , MS, professor of medicine, division of gastroenterology, … among rifaximin-treated participants . “In addition, rifaximin treatment …

… MT versus rifaximin MT using data from two randomized trials of … ). During six months of treatment, rifaximin MT reduced the risk for … disclosed ties to pharmaceutical companies, including Salix Pharmaceuticals, which manufactures rifaximin. Abstract More …

… Medicine, said at the ACG Annual Scientific Meeting. “Rifaximin … encephalopathy,” Bajaj said. “Rifaximin treatment may confer a survival … analysis of two randomized trials. Presented at: ACG … a clinical trial investigator for Salix Pharmaceuticals. Please see …

Third quarter revenue was $10.60 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.25. Third quarter adjusted EPS was $5.28. Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the quarter …

… well-known pharmaceutical companies’ products, including widely prescribed drugs like paracetamol … drugs are treatments that have seen increased use over the years. Common medications … Vitamin C Softgels Rifamin 550 (Rifaximin Tablets 550 mg) Pantoprazole …

… Paracetamol, blood pressure (BP) medications, anti-diabetes drugs, vitamins, and calcium supplements … including Unicure India Ltd, Hetero Drugs, Health Biotech Ltd, Alkem Laboratories, Hindustan … SR-500 6. Rifmin 550 (Rifaximin Tablets 550 mg) 7. Pantoprazole …

… Soft Caps, Rifmin 550 (Rifaximin Tablets 550 mg) manufactured by … 2025 M/s. Health Biotech Ltd., Village: Sandoli, Nalagarh … M/s. Nandani Medical Laboratories Pvt. Ltd., 221… . (A Subsidiary of Akums Drugs & Pharmaceuticals Ltd.) Plot No. Vardhman …

… by nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin, … trials to compare the effectiveness of mucoprotectants for the treatment … , equalen, muscovite, and rifaximin. The primary outcome was … , Department of Internal Medicine, the Catholic University …

… 7% of annual pharmaceutical spend on infectious disease treatments, according to a … To evaluate drug expenditure in healthcare, Vizient collected medication spend data … #47;velpatasvir) — Hepatitis C 6. Xifaxan (rifaximin) — Traveler's diarrhea, hepatic …

… participants completed a ten-day medically supervised weight loss program, including … bioenergetics. In the randomized clinical trial, 44 obese individuals were randomly … . They then received the antibiotic rifaximin while continuing their assigned diets …